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Abstract
Multiple pluripotent cell populations, which together comprise the pluripotent cell lineage,
have been identified. The mechanisms that control the progression between these popula-
tions are still poorly understood. The formation of early primitive ectoderm-like (EPL) cells
from mouse embryonic stem (mES) cells provides a model to understand how one such
transition is regulated. EPL cells form from mES cells in response to L-proline uptake
through the transporter Slc38a2. Using inhibitors of cell signaling we have shown that Src
family kinases, p38 MAPK, ERK1/2 and GSK3β are required for the transition between
mES and EPL cells. ERK1/2, c-Src and GSK3β are likely to be enforcing a receptive,
primed state in mES cells, while Src family kinases and p38 MAPK are involved in the
establishment of EPL cells. Inhibition of these pathways prevented the acquisition of most,
but not all, features of EPL cells, suggesting that other pathways are required. L-proline
activation of differentiation is mediated through metabolism and changes to intracellular
metabolite levels, specifically reactive oxygen species. The implication of multiple signaling
pathways in the process suggests a model in which the context of Src family kinase activa-
tion determines the outcomes of pluripotent cell differentiation.
Introduction
The pluripotent cell lineage in the mouse embryo is founded in the forming blastocyst and
develops through a series of functionally distinct intermediate populations before
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differentiating at gastrulation. Four identifiable pluripotent cell populations, or states, have
been identified in vivo–the epiblast precursor cell, the epiblast of the Inner Cell Mass (ICM),
and the early and late epiblast of the post-implantation embryo [1–3]. Culture equivalents of
these populations have been established frommouse. Primed embryonic stem (mES) cells [4,
5] and epiblast stem cells (EpiSCs) [6–8], which represent the epiblast of the ICM and the late
epiblast of the post-implantation embryo, respectively, have been isolated directly from the
embryo. Naive ES cells, an in vitro equivalent of the early epiblast of the ICM, have been
formed from primedmES cells in culture [9–12]. Lastly, the epiblast, or primitive ectoderm,of
the early post-implantation embryo can be formed in culture through the differentiation of
primedmES cells to early primitive ectoderm-like (EPL) cells [13],[14, 15]. EpiSC-like cells can
also be derived frommES cells by culture in FGF and Activin A [16–18]. These populations of
pluripotent cells are now well recognized, but the molecularmechanisms that regulate progres-
sion between them are not well understood.
EPL cell formation occurs whenmES cells are cultured in MEDII, medium conditioned by
HepG2 cells [13–15], or in medium containing the active component of MEDII, L-proline [19–
22]. Expression of Oct4, Sox2 and alkaline phosphatase, and a differentiation potential in cul-
ture that includes mesoderm, endodermand ectoderm, identifies EPL cells as pluripotent [13,
23–28]. The changes in colony morphology, gene expression [13, 14, 24, 29], proliferation rate
[20], and developmental potential [15, 24, 25] that accompany EPL cell formation identify
these cells as primitive ectoderm-like.EPL cell formation is dependent on elevated concentra-
tions of L-proline within the medium (> 100 μM) [19, 20], and is inhibited by LIF [13]. The
uptake of L-proline through the sodium-coupled neutral amino acid transporter 2 (Slc38a2,
also known as SNAT2) on the surface of the cells is required for activity, and the inhibition of
L-proline uptake through SNAT2 prevents EPL cell formation [19]. Collectively, these studies
describe a system that models the transition from the epiblast of the ICM to early primitive
ectoderm, and that can be used to understand the regulation of this event.
Little is known of how the internalization of L-proline by ES cells, when presented in MEDII
or added exogenously, induces EPL cell formation. Changes in cell morphology characteristic
of the system have been shown to require the metabolism of L-proline and generation of reac-
tive oxygen species (ROS) [21]. Here we consider the role of signaling pathways in EPL cell for-
mation. We describe the effect of pharmacologically inhibiting the Src family kinases and
mitogen-activated protein kinase (MAPK) pathways (p38 MAPK and Extracellular signal-reg-
ulated kinases 1 and 2 (ERK1/2)) on the formation and maintenance of EPL cells. We show
that inhibition of Src family kinases and p38 MAPK pathways, and pathways implicated in
naïve cell formation, affected the formation and maintenance of EPL cells. Inhibition of a single
pathway could not completely prevent EPL cell formation, suggesting the requirement of mul-
tiple signaling pathways in the process. These data have been used to develop a model for the
process of pluripotent cell lineage progression and the formation of the primitive ectoderm
based on a metabolic switch and increasing intracellular ROS.
Results
Inhibition of ERK1/2 signaling prevents EPL cell formation and
maintenance in culture
EPL cells are routinely formed from primedmES cells in culture [13, 20]. The inhibition of
ERK activity in mES cells promotes the transition of primedmES cells to the naive state [9, 11].
The ability of MEDII to induce EPL cells from a mES cell population in whichMEK1 signalling
had been inhibited, and therefore lacking phosphorylated ERK1/2, was tested. Phosphorylated
(p)ERK2 was detected in ES cells; phosphorylation was lost in cells cultured with the MEK
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inhibitor PD0325901 [30](Table 1; Fig 1A). Addition of PD0325901 to ES cells in conjunction
with MEDII or L-proline prevented the adoption of EPL cell-like colony morphology (Fig 1B
and 1C; data not shown). The cells were analysed by qPCR for the expression of markers of
pluripotency (Oct4, Sox2 and Nanog), the early epiblast of the ICM/ES cells (Rex1, Spp1 and
Gbx2) and the primitive ectoderm/EPLcells (Dnmt3b, Otx2 and Fgf5;Fgf5was only examined
in cells cultured in MEDII [20]). Cells cultured in MEDII + PD0325901 failed to up regulated
Fgf5 and Dnmt3b expression and maintainedNanog, Rex1 and Spp1 expression when com-
pared to cells cultured in MEDII, consistent with maintenance of an ES cell-like state in the
absence of MEK activity (Fig 1D).
EPL cell formation requires signaling through SRC family kinases
There are nine members of the Src family kinases, seven of which have been shown to be
expressed in mES cells; c-Src, p56Lck, p59FynT, Hck, Lyn, Fgr and Yes [30, 38, 47](JK, EW and
JR, personal communication), and c-Src activity is required for the formation of a primitive
ectoderm-like cell frommES cells in culture [38, 39]. PP2, at a concentration of 10 μM, was
used to inhibit Src, p56Lck, p59FynT and Hck in mES cells (Table 1). At this concentration the
phosphorylation of Src family members was reduced (Fig 2A) and cells did not adopt an EPL
cell colony morphology in response to MEDII (S1 Fig). The addition of PP2 reduced colony
size, which was likely a consequence of the inhibition of pluripotent cell proliferation (S1 Fig).
The addition of PP2 maintained or increased the expression of pluripotent and mES cell mark-
ers, with the exception of Gbx2, in mES cells cultured in MEDII- or L-proline-containing
medium, and reduced the expression of Dnmt3b and Fgf5, but not Otx2, (Fig 2D and S2 Fig).
When differentiated as embryoid bodies (EBs), EPL cells increase expression of differentia-
tion markers earlier than mES cells [20, 24]. mES cells and EPL cells were aggregated to form
EBs and analysed on days 2, 3 and 4 for the expression of markers of the primitive streak (T,
Mixl1, Fgf8,Wnt3 and Tgfβ1) and nascent mesoderm (BMP4) by RT-PCR (Fig 2D). Differenti-
ation markers were up regulated approximately 48 hours earlier in EBs derived from EPL cells
when compared to those derived frommES cells. EBs derived frommES cells cultured in
MEDII supplemented with PP2 up regulated differentiationmarkers approximately 24 hours
earlier than mES cell-derived EBs (Fig 2E, S1 Fig). The advancement of differentiated gene
expression in EBs derived from cells cultured in L-proline has always beenmuch less than in
EBs derived from EPL cells [20]. Despite this, the addition of PP2 to the cells prior to the
Table 1. Summary of inhibitors used in this study.
Compound Chemical name [μM] Type of inhibition Specificity References1
PD0325901 N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-
4-iodophenyl)amino]-benzamide
1 Non-ATP competitive
binding inhibition
MEK12,4 [9, 11, 31–33]
PP2 Pyrazolo-pyrimidine 4-amino-5-(4-chlorophenyl)-7-(t-
butyl)pyrazolo[3,4-d]pyrimidine
10 ATP competitive
binding inhibition
Src4, p56Lck,4, p59FynT,4, Hck4,
EGFR5, RIP25, CK1δ5 and GAK5.3
[34–39]
SB203580 4-(4´-fluorophenyl)-2-(4´-methylsulfinylphenyl)-5-(4
´-pyridyl)-imidazole
10 ATP competitive
binding inhibition
p38αMAPK4, p38β MAPK4 and
CK1δ5.
[31–33, 40–
44]
SU6656 2-oxo-3-(4,5,6,7-tetrahydro-1 H-indol-2-ylmethylene)-
2,3-dihydro-1H-indole-5-sulfonic acid dimethylamide
ATP competitive
binding inhibition
MAPKAP-K1a4, AMPK4, PHK5,
p56Lck,4 and DYRK1A4.
[34, 45, 46];
1 Selected references, prioritized to include those reporting on role of inhibitor in ES cell renewal and differentiation.
2 Inhibitor is reported to have activity on MEK1 but not on ERK1, ERK2, p38αMAPK or p38βMAPK [34].
3 PP2 has been shown to have a modest impact on the activity of p38αMAPK, p38β MAPK [34].
4 Detected in ES cells.
5 Not reported in ES cells.
doi:10.1371/journal.pone.0163244.t001
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Fig 1. Inhibition of MEK1 prevents the formation of EPL cells in response to MEDII. A. mES cells were pre-treated with 1 μM
PD0325901 for 60 minutes. 200 μM L-proline was added, as denoted, and the cells incubated for a further 60 minutes. Cells were
collected and analysed by western blot for the presence of phosphorylated ERK1 or ERK2. Total ERK1/2 was used as a loading control.
The intensity of the pERK2 band was measured using Quantity One software (BioRad) and represented as a proportion of total ERK1/
2. Error bars represent SEM; n = 4; * p 0.05 when compared to mES cells. B-C. mES cells were cultured in MEDII- and DMSO-
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formation of EBs did impact differentiation kinetics, with a delay in the expression of the dif-
ferentiation marker T (S2 Fig).
p38 MAP Kinase in EPL cell formation
A kinome screen of mES cells exposed to L-proline showed increased phosphorylation of p38α
MAPK, p38βMAPK and Heat shock protein 2 (Hspb2, also known as Hsp27) (S3A Fig), sug-
gesting that the p38 MAPK pathway could be activated [48, 49]. MAP kinase pathways have
been implicated in early mES cell differentiation decisions and the formation of the germ line-
ages in culture [31–33, 40–44]. Western blot showed the presence of pHspb2 in mES cells and
mES cell treated with L-proline (Fig 3A). PhosphorylatedHspb2 levels were significantly
reduced in by the inhibitor SB203580 (Fig 3A).
The addition of 10 μM SB203580 during EPL cell formation resulted in subtle changes in
colony morphology across the population, with many colonies having a more rounded appear-
ance and refractive edges, characteristics of mES cell colonies and not EPL cell colonies (Fig 3B
and 3C; data not shown). The expression of Dnmt3b and Fgf5, but not Otx2, was reduced with
the addition of SB203580 to cells cultured in MEDII-containing or L-proline-containing
medium (Fig 3D and S2 Fig). These data suggest that p38 MAPK was required for the
increased expression of these genes. The expression of Rex1, Spp1 and Gbx2 was generally unaf-
fected by the addition of SB203580 and was not restored to levels comparable those in
untreated mES cells. mES cells cultured in MEDII- or L-proline-containing medium and
SB203580 were differentiated as EBs and the expression of T analysed (Fig 3E and S2 Fig).
SB203580 prevented the acquisition of EPL cell differentiation kinetics.
mES cells that lack the p38αMAPK isoform have been established [50]. p38α-/-cells showed
equivalent expression of Nanog, Rex1 and Spp1 when compared to the parental line, but higher
expression of Gbx2 and significantly lower basal expression of Dnmt3b, Otx2 and Fgf5 (S3B
Fig). The addition of MEDII to p38α-/-mES cells resulted in increased expression of the primi-
tive ectodermmarkers. These cells, however, failed to down-regulation the ES cell markers
(S3C Fig). These data suggest that the loss of p38α affects the formation of EPL cells frommES
cells but did not recapitulate the addition of SB203580.
The role of signaling pathways in the maintenance of EPL cells in culture
Signaling through the ERK2, Src family kinase and p38 MAPK all play a role in the formation
of EPL cells frommES cells. Signaling inhibitors were added to extant EPL cells to assess the
roles these pathways may play in EPL cell maintenance. Inhibition of MEK1/ERK2 in EPL cells
resulted in a mixed population of pluripotent and differentiated cell colonies, with alkaline
phosphatase positive cell colonies, adopting a compact, 3-dimensional structure rather than an
epithelial structure (Fig 4A and 4B). The population showed a significant up regulation of
Nanog, Rex1 and Spp1 expression, maintenance of Oct4 and Sox2 expression and a reduction
in EPL cell marker expression when compared to EPL cells (Fig 4E). The addition of PP2 to
EPL cells also disrupted colony morphology, with a number, but not all, colonies within the
culture rounding up (Fig 4C); these colonies were positive for alkaline phosphatase activity.
These cells expressed significantlymore Nanog and Sox2 compared to EPL cells. Increased
containing medium (B) and MEDII- and 1μM PD0325901-contianing medium (C) for 3 days. Scale bar = 200 μm. D. MEDII- and DMSO-
containing medium (■) and MEDII- and 1μM PD0325901-contianing medium (□) for 3 days. RNA from these cells was analyzed for
expression of Oct4, Sox2, Nanog, Rex1, Spp1, Gbx2, Dnmt3b, Otx2 and Fgf5 by real-time PCR. Expression was normalized to β-actin
and expressed relative to mES cells (Fgf5 has been expressed relative to MEDII + DMSO). Error bars represent SEM; n = 3. mES cells
+ MEDII + PD0325901 were compared to mES cells + MEDII + DMSO (** p 0.05) or mES cells (# p 0.05).
doi:10.1371/journal.pone.0163244.g001
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expression of Rex1 and Spp1, and decreased expression of Dnmt3b and Fgf5, in these cells was
consistent with the cells acquiring a more ES cell-like gene expression profile (Fig 4F). These
changes did not all reach parity with ES cell gene expression (data not shown). The expression
of Gbx2 and Otx2was unaffected by the addition of PP2. EPL cells in which p38 MAPK had
been inhibited appeared to be more differentiated than controls and there were qualitatively
fewer alkaline phosphatase cells (Fig 4D). Gene expression analysis detected no significant dif-
ferences in the expression of the pluripotent, ES cell or EPL cell markers (Fig 4G), suggesting
that an EPL cell gene expression profile was maintained. Despite the appearance of more differ-
entiated cells within this population, gene expression analysis could not detect a role for p38
MAPK in EPL cell maintenance.
ROS-signalling and EPL cell formation
Several lines of evidence suggest that c-SRC can be activated by increased intracellular ROS
[16, 51]. Likewise, others have implicated ROS in the activation of p38 MAPK (for example
[52–54]). Metabolism of L-proline by proline dehydrogenase within the cell can result in
increased intracellular ROS levels [55], providing a potential link between L-proline uptake and
signaling pathway activation. mES cells with and without L-proline were assayed for steady
state levels of intracellular ROS qualitatively and quantitatively (Fig 5). Qualitatively, a popula-
tion of ES cells comprised a mix of ROS-bright and ROS-dull cells (Fig 5A); this was reflected
in a basal level of biochemically detected ROS within the population (Fig 5D). The addition of
L-proline resulted in an increase in the number of ROS-bright cells in the population and a con-
comitant increase in the levels of ROS detected (Fig 5B and 5D). The PRODH inhibitor
3,4-dehydro-L-proline (DHP) reduced the levels of ROS in L-proline-treated cells to basal lev-
els, but had no impact on ROS levels in untreated mES cells. Addition of an antioxidant, ascor-
bic acid (Fig 5C) or glutathione (GSH; Fig 5D), abolished ROS-bright cells in the population
and reduced the levels of ROS to below basal (mES cell) levels. Finally, inhibiting L-proline
metabolismwith DHP reduced the expression of Dnmt3b and Otx2 in L-proline-treated cells
(Fig 5E), suggesting a requirement for metabolism in the regulation of EPL cell gene
expression.
Discussion
EPL cell inductive factors act on a primed ES cell population
mES cells can be cultured in the naïve or the primed state. The naive pluripotent cell state is
achieved by preventing signaling through ERK1/2 in combination with a GSK3ß inhibitor, and
thereby maintaining cells in an intrinsically self-maintaining state regulated by Nanog and
shielded from differentiation signals [9, 11]. With increasing ERK signalingmES cells become
primed, or able to respond to differentiation signals [31], while deletion of Erk2-/- biases cells
Fig 2. Src Family Kinases are required for the formation of EPL cells in response to MEDII A. mES cells were
cultured with or without L-proline and PP2, as denoted. Total protein was extracted after 24 hours and analysed by
western blot for the presence of phosphorylation of Src family proteins (pSFK). β-tubulin was used to normalise for
protein loaded. B, C. mES cells were cultured in medium supplemented with MEDII and DMSO (A) or MEDII and
10 μM PP2 (B) for 3 days. Scale bar = 200 μm. D. mES cells were cultured in medium supplemented with MEDII and
DMSO (■) or MEDII and 10 μM PP2 (□), for 3 days. RNA from these cells was analyzed for transcripts of Oct4, Sox2,
Nanog, Rex1, Spp1, Gbx2, Dnmt3b, Otx2 and Fgf5 by real-time PCR. Expression was normalized to β-actin and
expressed relative to ES cells (Fgf5 has been expressed relative to MEDII + DMSO). Error bars represent SEM;
n = 3. ES cells in MEDII + PP2 were compared to cells cultured in MEDII + DMSO (** p 0.05) or ES cells (#
p 0.05). E. mES cells were cultured in ES cell medium supplemented with MEDII, DMSO or MEDII and 10 μM PP2
for 3 days and formed into EBs. EBs were collected on days 2, 3 and 4, RNA was isolated and analyzed for
expression of T, Mixl1 and Gapdh by RT-PCR. n = 3.
doi:10.1371/journal.pone.0163244.g002
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towards self-renewal [56]. Inhibition of ERK2 signaling prevented the formation of EPL cells in
response to l-proline or MEDII, suggesting that active ERK2, and the concomitant primed
mES cell state, was required for EPL cell formation. Inhibition of Src activity can replace the
inhibition of ERK signaling in the maintenance of naïve mES cells [57, 58], and c-Src inhibition
has been shown to promote the formation of naïve human pluripotent cells [59]. The ability of
PP2 to inhibit the formation of EPL cells from ES cells in response to l-proline or MEDII is
consistent with a requirement for a primedmES cell substrate in primitive ectoderm
formation.
Acquisition and maintenance of the EPL cell state requires the activity of
multiple intracellular pathways
Src family kinase signaling was required for the maintenance of the EPL cell state in culture,
and suggests a role for this pathway beyond facilitatingmES cell priming. Several reports have
noted the functional similarity between human (h)ES cells and primitive ectoderm-like cell
lines frommouse, EPL cells and EpiSCs [26, 60, 61]. Pluripotency in hES cells is maintained, in
part, by fibroblast growth factor-2 (FGF-2). Analysis of the pathways activated by FGF signal-
ling in hES cells demonstrated tyrosine phosphorylation of Src family kinases and Src sub-
strates [62]. This was interpreted as indicating a role for Src kinase activity in the maintenance
of hES cell pluripotency by FGF-2, and is consistent with the role of Src family kinase activity
in maintaining the primitive ectoderm-like identity of EPL cells in culture.
The formation of EPL cells frommES cells, like the formation of primitive ectoderm from
pluripotent cells of the blastocyst, is accompanied by epithelialisation of the pluripotent cells.
PP2 prevented this change in colony morphology and promoted growth in compact colonies;
others have seen this effect [63]. This effect has also been seen in non-pluripotent cells, in
which PP2 inhibited cell migration, and also, surprisingly, in fibroblasts deficient in c-Src, Yes
and Fyn, suggesting that migration in these cells depended on a non-Src family kinasemecha-
nism that is affected by PP2 [63]. Consistent with this, the Src family inhibitor SU6656 did not
inhibit the epithelialisation of mES cells cultured in MEDII (Data not shown). It is yet to be
determined if the mechanisms that regulate colony morphology changes seen in pluripotent
cell lineage progression are equivalent to those that regulate migration in somatic cells.
Treatment of mES cells with L-proline resulted in increased p38 MAPK phosphorylation.
Inhibition of p38 MAPK activity during EPL cell formation impacted the change in colony
morphology, prevented the up regulation of primitive ectodermmarkers Dnmt3b and Fgf5 and
blocked the change in differentiation kinetics that accompanies EPL cell formation, suggesting
a role for p38 MAPK in the establishment of EPL cells. Inhibiting signaling through p38
MAPK did not, however, restore the expression of pluripotent / ES cell markers. The deletion
of p38α resulted reduced basal expression of primitive ectodermmarkers when compared to
Fig 3. The role of p38 MAPK in the formation of EPL cells in response to MEDII. A. mES cells were pre-
treated with 10 μM SB203580 for 60 minutes. 200 μM L-proline was added, as denoted and the cells
incubated for a further 60 minutes. Cells were collected and analysed by western blot for the presence of
phosphorylated pHspb2. Total Hspb2 was used as a loading control. B, C. mES cells were cultured medium
supplemented with MEDII and DMSO (A) or MEDII and 10 μM SB203580 for 3 days. Scale bar = 200 μm. D.
mES cells were cultured in medium supplemented with MEDII and DMSO (■) or MEDII and 10 μM SB203580
(□) for 3 days. RNA from these cells was analyzed for expression of Oct4, Sox2, Nanog Rex1, Spp1, Gbx2,
Dnmt3b, Otx2 and Fgf5 by real-time PCR. Expression was normalized to β-actin and expressed relative to
mES cells (Fgf5 has been expressed relative to MEDII + DMSO). Error bars represent SEM; n = 4. mES cells
+ MEDII + SB203580 were compared to mES cells + MEDII + DMSO (** p 0.05) or mES cells (# p 0.05).
E. mES cells were cultured in ES cell medium supplemented with MEDII, DMSO or MEDII and 10 μM 10 μM
SB203580 for 3 days and formed into EBs. EBs were collected on days 2, 3 and 4, RNA was isolated and
analyzed for expression of T and Gapdh by RT-PCR. n = 3.
doi:10.1371/journal.pone.0163244.g003
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WT cells; expression of these markers increasedwith the addition of MEDII but there was no
accompanying alteration in differentiation kinetics (data not shown). Previous reports showed
that knockdown of p38δ, the second highest p38 MAPK isoform found in ES cells, in p38α-/-
ES cells did not affect ES cell differentiation [64]. Although the loss of p38α did prevent aspects
of EPL cell formation, p38α-/-mES cells do not phenocopy mES cells cultured in a p38 MAPK
inhibitor, suggesting that in the absence of other p38α factors, including p38β, may regulate
EPL cell marker gene expression.
Multiple pathways regulate pluripotent lineage progression
MES cells in culture do not grow as a homogenous population but exist in a metastable state.
Heterogeneity has been revealed by the non-uniform expression of Zfp42,Dppa3,Nanog,
Pecam1 and Otx2 in cells expressingOct4 [65–70]. These genes mark interchangeable pluripo-
tent cell states corresponding to an ICM-like,Otx2-low state and a later pluripotent cell state,
marked by higherOtx2 expression, that coexist and ensure the self-renewal and perpetuation
of pluripotency and a susceptibility to differentiation factors [10].Otx2 has been shown to be
Fig 4. The role of ERK1/2, Src Family Kinases and p38 MAPK in the maintenance of EPL cells. A-D.
Photomicrographs of mES cells cultured in MEDII for 2 days and subsequently in MEDII containing medium
supplemented with DMSO (A), 1 μM PD0325901 (B) 10 μM PP2 (C) and 10 μM SB203580 (D). Cells were
stained for alkaline phosphatase activity (red/purple stain). Scale bar = 200 μm. E, F. mES cells were
cultured in MEDII for 2 days and subsequently in MEDII containing medium supplemented with DMSO (■),
DMSO with 1 μM PD0325901 (E, □), DMSO with 10 μM PP2 (F, □) or DMSO with 10 μM SB203580 (G, □).
RNA from these cells was analyzed for expression of Oct4, Sox2, Nanog, Rex1, Spp1, Gbx2, Dnmt3b and
Otx2 by real-time PCR. Expression was normalized to β-actin. Error bars represent SEM; n = 3. EPL cells
cultured in MEDII with inhibitor were compared to EPL cells in MEDII with DMSO, ** p 0.05, or mES cells,
# p 0.05.
doi:10.1371/journal.pone.0163244.g004
Fig 5. The addition of L-proline to ES cells increases ROS. A-C. MitoSox Red staining of mES incubated with 200 μM l-proline (B) or L-proline and
ascorbic acid (C) and compared to untreated cells (A). Hoechst staining of the same fields of view are shown in Ai, Bi and Ci. D. ROS levels were measured
as fluorescence using ROS-Glo™H2O2 Assay (Promega) in cells that had been incubated with L-proline, 150 μM DHP or 1 mM GSH, as denoted. Results
are shown as arbitrary fluorescent units. n = 4, *p0.05 when compared with mES cells. # p0.05 when compared with mES cells incubated with L-proline.
E. The expression of Dnmt3b and Otx2 was analysed in mES cells cultured in medium supplemented 200 μM L-proline or 200 μM L-proline and 150 μM
DHP. Expression was normalized to β-actin and expressed relative to mES cells. Error bars represent SEM; n = 4. Comparisons were made to mES cells
(*p 0.05) or mES cells cultured with 200 μM L-proline (# p 0.05).
doi:10.1371/journal.pone.0163244.g005
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intrinsic to the metastable state; overexpression of Otx2 resulted in a population of cells repre-
sentative of late epiblast of the post-implantation embryo and EpiSC, whileOtx2-/-mES cells
are highly enriched for Nanog-expressing cells and predisposed to self-renewal [69]. Otx2 has
also been shown to be required for the transition of mES cells from the ICM-like state and
later, primed, pluripotent cell states [71].Otx2 has been used here as a marker of EPL cells.
Inhibition of neither Src family kinases, p38 MAPK, nor MEK1/ERK2 affected the regulation
of Otx2 expression during the formation of EPL cells, although the loss of ERK1/2 signalling in
formed EPL cells did reduce the expression of Otx2 (S4 Fig). The inability to prevent Otx2
expression whenmES cells are exposed to L-proline or MEDII may underlie the failure of these
inhibitors to prevent all aspects of differentiation and to maintain an mES cell in culture.
Fig 6. The regulation of progression of the pluripotent lineage in culture. The cell states represented in vitro,
naïve mES cells, primed mES cells and EPL cells have been aligned with the expression of Nanog and Otx2 and
with their deduced intracellular signaling activity. Inducers of lineage progression are shown in orange; Calcineurin
exerts its effects through dephosphorylation of NFAT and promotes NFAT translocation to the nucleus.
doi:10.1371/journal.pone.0163244.g006
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Several transcriptional modules have been identified in the regulation of mES cells pluripo-
tency, each potentially regulating different gene cohorts and regulated by different upstream
triggers [72–76]. It is likely that Src family kinases, p38 MAPK and ERK2 signaling regulate
some, but not all, of these transcriptional modules, resulting in the incomplete inhibition of
EPL cell formation and maintenance of Otx2 expression.
Multiple pluripotent cell states in culture
The regulation of pluripotent lineage progression is not well understood, but these findings,
coupled with the findings of others, can be integrated into a model of the process (Fig 6). In
culture, mES cells in the naïve state are hypothesized to represent the earlier pluripotent cells of
the lineage [12, 77]. In culture, these cells are maintained by supressing GSK3β signaling in
combination with the inhibition of ERK1/2 signaling (through the inhibition of MEK1), Src
family kinases or calcineurin [9, 11, 57, 58]. It is thought that calcineurin signaling collaborates
with ERK signaling to activate Src, which in turn drives the priming of the cells for differentia-
tion [58]; inhibition of any of these signalling components will prevent Src activation. In
primedmES cells ERK activity is present. The absence of calcineurin signaling in these cells
[58] will likely prevent the up regulation and activation of c-Src in response to ERK1/2
signaling.
The transition of mES cells to EPL cells involves the activation of Src family kinases and p38
MAPK and occurs in response to L-proline. The addition of L-proline to primedmES cells
increases ROS within the cell population. The enzyme central to proline metabolism in the cell,
proline dehydrogenase (PRODH or POX), converts L-proline to Δ1-pyrroline-5-carboxylate
(P5C), with the concomitant transfer of electrons to oxygen and generation of ROS [78, 79].
ROS increases in mES cells were prevented by inhibition of PRODH, and EPL cell morphology
could be prevented by ROS scavengers and PRODH inhibition [21], suggesting a role for pro-
line metabolism in mES cell differentiation. c-Src and p38 MAPK can be activated by increased
intracellular ROS [51, 53, 54, 80], providing a pathway for the control of differentiation by L-
proline. The action of MEDII and L-proline, through ROS induction, does not appear to be
able to overcome the suppression of Src activation that can be achieved whenMEK1 is
inhibited.
The question arises to the relevance of calcineurin or L-proline in the regulation of Src activ-
ity within ES cells. The combination of ERK and calcineurin resulted in differentiation of mES
cells to cells of the extraembryonic lineages, primarily trophectodermand endoderm [58],
whereas the combination of ERK and L-proline results in the formation of EPL cells and subse-
quently cells of the germ lineages [15, 24, 25, 81]. These likely represent different pathways to
activate c-Src that achieve alternate cellular outcomes, potentially through the differential regu-
lation of p38 MAPK, and place Src family kinase signaling as pivotal in ES cell differentiation.
Materials and Methods
Cell culture
D3mouse mES cell line [82] was maintained as describedpreviously in Rathjen and Rathjen,
2003 [83]. EPL cells were formed by culturingmES cells in medium supplemented with 50%
MEDII, or medium supplemented with LIF and 200 μM L-proline (Sigma-Aldrich) [20, 83].
Chemical inhibitors (PP2 (Calbiochem), SB203580 (Tocris Bioscience), SU6656 (Sigma
Aldrich) and PD0325901 (Selleck Chemicals)) were added every 24 hours or as described in
the text. Inhibition of SRC family kinase phosphorylation by PP2 was still apparent at 24 hours
(Fig 1G), suggesting this inhibitor was stable in these culture conditions. Inhibition p38 MAPK
by SB203580 was clear after 60 minutes (Fig 3A) but was less predictable at 24 hours (data not
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shown), suggesting activity remained after extended culture but some potency had been lost.
Inhibition of ERK2 phosphorylation by PD0325901 was obvious after 60 minutes (Fig 5A) but
was not detected at 24 hours (data not shown), suggesting this inhibitor was not stable in cul-
ture over this time. MES cells were seeded at a density of 2.5 x 104 cells / cm2 onto tissue cul-
ture-treated plasticware (NuncTM), pretreated with 0.2% fetal porcine gelatin (Sigma-Aldrich).
Cells were cultured for 3 days (in 50%MEDII) or 4 days (with 200 μM L-proline) with daily
medium replenishment. Chemical inhibitors were suspended in dimethyl sulfoxide (DMSO)
(Sigma-Aldrich) and added to cells as described in the text. For EPL cell maintenance experi-
ments mES cells were cultured in medium supplemented with 50%MEDII for 2 days, followed
by the addition of chemical inhibitors to the medium for a further 2 days, as described in text.
Alkaline phosphatase activity was performed according to manufacturer’s instructions using
an alkaline phosphatase detection kit (Sigma-Aldrich; catalogue # 86C) with modifications to
allow staining in tissue culture plasticware [13]. Images were taken on an Olympus IX51 with
an F-view II digital camera (Olympus) or UC-30 digital camera. Embryoid bodies (EBs) were
formed frommES cells that had been cultured for 3 days (in 50%MEDII) or 4 days (with
200 μM L-proline) as describedpreviously [83]; chemical inhibitors were added as described in
text.
Gene expression analysis
Reverse Transcriptase-PCR (RT-PCR): Total RNA was isolated from cells using TRIzol1
reagent (InvitrogenTM) as per the manufacturer’s instructions and DNaseI treated (Ambion).
cDNA synthesis was performed usingM-MLV Reverse Transcriptase (Promega). PCR reac-
tions, containing GoTaq1 GreenMaster Mix (Promega), 200 nM each of forward and reverse
primers and 1 μl of cDNA were initially heated to 95°C for 2 minutes and then cycled through
95°C for 30 seconds, 60°C for 30 seconds and 72°C for 30 seconds on a MJ Research or Bio-rad
thermocycler. Primer sequences, the number of cycles used for each primer pair and the size of
the expected amplicon are listed in S1 Table.
Quantitative Real-time PCR (qPCR)
RNA was isolated, DNaseI treated and cDNA was synthesized as for RT-PCR. Reactions, con-
sisting of cDNA, HOT FirePol EvaGreen Mix (Integrated Sciences) with 200 nM each of for-
ward and reverse primers, were amplified usingMJ research thermocyclerwith a Chromo4
Continuous FluorescenceDetection System (MJ Research) or ViaTM 7 real time PCR system.
The samples were initially heated to 95°C for 15 minutes followed by 40 cycles of 95°C for 15 s,
60°C for 15 s and 72°C for 30 s. The cycle threshold (Ct) values for β-actin were normalized
across samples and the raw Ct values were analyzed using Q-Gene software package [84].
Primer sequences are listed in S1 Table.
Western Blot
Total cellular protein was extracted frommES cells with 200 μl Laemmli sample buffer (Bio-
rad) containing β-mercaptoethanol (Sigma-Aldrich), protease inhibitor (#P-8350; Sigma-
Aldrich) and phosphatase inhibitor, as per manufacturer’s instructions. Protein extract was
incubated at 100°C for 10 minutes and separated using a 10% SDS polyacrylamide gel. Stan-
dard immunoblot procedures were followed and proteins were visualized using the Immun-
StarTM WesternCTM ChemiluminescenceKit (Bio-Rad) and a Bio-Rad ChemiDocTM XRS as
per the manufacturer’s instructions. Antibodies, antibody suppliers and dilutions used are
stated in S1 Table. Band intensities were estimated using Quantity One software (Bio-Rad).
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Kinome array
mES cells were transferred to DMEM + 0.1% FCS (Life technologies) for 4 hours prior to set-
ting up the assay. At time 0, cells were mechanically removed from the plastic and aliquots of
approximately 1 x 107 cells were treated with LIF (5 minutes), 200 μM L-proline (5 and 15 min-
utes) or maintained in DMEM + 0.1% FCS (15 minutes). Cells were lysed and lysates applied
to a Proteome ProfilerTM Human Phospo-MAPKArray (R&D Systems, catalogue # ARY002B)
as per the manufacturer’s instructions. Signals were developed using enhanced chemilumines-
cence (GE Lifescience) and quantified using QuantityOne (Bio-Rad).
BrdU Assay
mES cells were cultured with 5’ Bromo 2’ deoxyuridine (BrdU) (10 μM; Sigma Aldrich) for 2
hours before cells were washed and reduced to a single cell suspension. Cells were fixed in ice-
cold 70% ethanol, permeabilised in 1 M HCl, and BrdU incorporation detected using an α-
BrdU monoclonal antibody (Bioclone Australia) in combination with a rabbit α-mouse IgG
Alexa Fluor 488 secondary antibody (Invitrogen). Cells that had incorporated BrdU were
quantified by flow cytommetry.
ROS analysis
Live cell imaging. mES cells were seeded at 2.5 x 104 cells per well into 96 well black imag-
ing plates (BD Falcon, 31053) and cultured for 4 days. L-proline (200 μM) was added on day 3,
and ascorbic acid (200 μM) was added 4 hours prior to imaging. 30 minutes prior to imaging,
MitoSOX™ Redmitochondrial superoxide indicator (5 μM, Invitrogen, M36008) and Hoechst
(Life Technologies, H3570) were added as per the manufacturer’s specifications. Cells were
washed in live cell imaging buffer (DMEMwithout Phenol Red (Gibco, 31053), 10% Foetal calf
serum (Life Technologies), 0.1mM β-mercaptoethanol (Sigma)) and imaged using a Leica
DMIRB inverted fluorescent microscope (LeicaMicrosystems), connected to a Hamamatsu
ORCA-ER digital camera. NIS Elements D software (version 4.0, Nikon1) was used to view
the images and control exposure times.
Biochemical analysis of ROS. ROS production was quantified using the ROS-Glo™ H202
Assay (Promega, G8820). MES cells were seeded at 1 x 106 cells per well into a 96 well white
imaging plates (BD Falcon, 351130) and allowed to adhere overnight. 200 μM L-proline was
added at the time of seeding as denoted in the text. 4 hours prior to performing the assay, DHP
(150 μM; Sigma Aldrich) or 1 mMGSH (Sigma-Aldrich, PHR1359) were. The H2O2 substrate
solution was added 1 hour after treatments were added and the plate was incubated at 37°C for
an additional 3 hours. Cells were washed with PBS, the ROS-Glo detection solution was added
to with PBS to a total volume of 200 μl and the cells were incubated at room temperature for 20
minutes. Luminescence readings were taken using the GloMax1 -96 Microplate luminometer
(Promega).
Statistical Analysis
Experiments were analyzed using one-way ANOVA followed by Tukey’s multiple comparison
post-hoc test and significancewas achieved at p = 0.05 or less with the use of Graphpad Prism.
Supporting Information
S1 Fig. PP2 impacts the colony morphology, proliferation rate and differentiation kinetics
of pluripotent cells in cluture. A. ES cells were cultured in ESCM and ESCM+ 200 μM L-pro-
line with or without 10 μM PP2, as indicated, for 4 days. Scale bar = 200 μm. B. ES cells were
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cultured in MEDII + DMSO and MEDII + 5, 10 or 20 μM PP2 for 3 days. Scale bar = 200 μm.
Although a clear change in the appearance of colonies could be seen with 5 μM PP2 when com-
pared to MEDII + DMSO, full suppression of EPL cell morphologywas seen at 10 and 20 μM.
C. ES cells were cultured with 5 and 20 μM PP2 for 5 (■) or 6 (□) days. Cells in S-phase were
identified by immunofluorescence for incorporated BrdU followed by flow cytometry. The
number of cells incorporating BrdU is shown relative to ES cells. Error bars represent SEM;
n = 3. Comparisons were made to untreated ES cells,  p 0.01. D. ES cells were cultured in
ESCM,MEDII, MEDII + DMSO and MEDII + 10 μM PP2, as indicated, for 3 days and formed
into EBs. EBs were collected on days 2, 3 and 4. RNA was isolated and analyzed for expression
of Fgf8,Wnt3, Tgfβ1,Bmp4 and Gapdh by RT-PCR; n = 3, a representative image is shown.
(TIF)
S2 Fig. The impact of signaling inhibitors on the action of L-proline. A, B. ES cells were cul-
tured in medium supplemented with 200 μM L-proline and DMSO (■) or L-proline and 10 μM
PP2 (□) (A) or 10 μM SB203580 (□)(B), for 4 days. RNA from these cells was analyzed for tran-
scripts of Oct4, Sox2,Nanog, Rex1, Spp1, Gbx2,Dnmt3b, Otx2 and Fgf5by real-time PCR.
Expression was normalized to β-actin and expressed relative to ES cells. Error bars represent
SEM; n = 3. ES cells in Proline + PP2 were compared to cells cultured in Proline + DMSO (
p 0.05) or ES cells (# p 0.05).C, D. ES cells were cultured with L-proline + DMSO, L-pro-
line +10 μM PP2 (C) and L-proline +10 μM SB203580 (D) for 4 days before being formed into
embryoid bodies (EBs). EBs were analysed as for the expression of T by RT-PCR. n = 3.
(TIF)
S3 Fig. A role for p38 MAPK signaling in EPL cell formation. A. ES cells were treated with
LIF or 100 μM of L-proline for 5 or 20 minutes, as indicated. Cells were lysed and protein
bound to the kinome array and binding quantified. Binding to antibodies specific
for pp38α, pp38β, pHsbp2 and MSK2 is shown; n = 2, values have been averaged. B.WTES
cell and p38α KO ES cells were cultured in ESCM. RNA was analyzed by qPCR for the expres-
sion of Nanog, Rex1, Spp1, Gbx2, Fgf5,Dnmt3b and Otx2. Expression was normalized to Oct4
and expressed relative to WT ES cells. Error bars represent SEM; n = 3. p 0.01 when com-
pared toWT ES cells. Loss of p38α decreased expression of primitive ectodermmarkers in the
ES cell population. C. p38α KO ES cells were cultured in ESCM and MEDII for 3 days to form
EPL cells. RNA was analyzed by qPCR for the expression of Nanog, Rex1, Spp1, Gbx2, Fgf5,
Dnmt3b and Otx2 by real-time PCR. Expression was normalized to Oct4 and expressed relative
to p38α KO ES cells. Error bars represent SEM; n = 3. p 0.01, p 0.05 when compared to
KO ES cells.
(TIF)
S4 Fig. The effect of inhibiting Src family kinase signaling with SU6656. ES cells were cul-
tured in MEDII + DMSO and MEDII + 1, 2 or 4 μM SU6656 for 3 days. Scale bar = 200 μm.
(TIF)
S1 Table. Details of primers and antibodies used in this research.
(DOCX)
Acknowledgments
The authors would like to thank members of the Rathjen laboratory for insightful discussions
of the project. This work was supported by the University of Melbourne, the Australian Stem
Cell Centre, Stem Cells Australia and the David Hay Postgraduate Writing up Award. BSNT
was supported by an Endeavour International Postgraduate Research Scholarship and a
Regulation of Pluripotent Lineage Progression
PLOS ONE | DOI:10.1371/journal.pone.0163244 October 10, 2016 16 / 21
Melbourne International Research Scholarship. CY was supported by an Australian Postgradu-
ate Awards with additional support from the Australian Stem Cell Centre.
Author Contributions
Conceived and designed the experiments:BSNT JK CKEWNS CY FFMMDKG PDR JR.
Performed the experiments:BSNT JK CKEWNS CY FF.
Analyzed the data: BSNT JK CKEWNS CY FFMMDKG PDR JR.
Wrote the paper:BSNT JR.
Critical revision of manuscript: BSNT JK CKEWNS CY FFMMDKG PDR JR.
References
1. Chazaud C, Yamanaka Y, Pawson T, Rossant J. Early lineage segregation between epiblast and prim-
itive endoderm in mouse blastocysts through the Grb2-MAPK pathway. Dev Cell. 2006; 10(5):615–24.
doi: 10.1016/j.devcel.2006.02.020 PMID: 16678776.
2. Pera MF, Tam PP. Extrinsic regulation of pluripotent stem cells. Nature. 2010; 465(7299):713–20. doi:
10.1038/nature09228 PMID: 20535200.
3. Rathjen J. The States of Pluripotency: Pluripotent Lineage Development in the Embryo and in the
Dish. ISRN Stem Cells. 2014;2014 Article ID 208067. doi: 10.1155/2014/208067
4. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature.
1981; 292(5819):154–6. doi: 10.1038/292154a0 PMID: 7242681.
5. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned
by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 1981; 78(12):7634–8. doi: 10.1073/pnas.78.
12.7634 PMID: 6950406; PubMed Central PMCID: PMC349323.
6. Brons IG, Smithers LE, Trotter MW, Rugg-Gunn P, Sun B, Chuva de Sousa Lopes SM, et al. Derivation
of pluripotent epiblast stem cells from mammalian embryos. Nature. 2007; 448(7150):191–5. doi: 10.
1038/nature05950 PMID: 17597762.
7. Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, et al. New cell lines from mouse
epiblast share defining features with human embryonic stem cells. Nature. 2007; 448(7150):196–9.
doi: 10.1038/nature05972 PMID: 17597760.
8. Kojima Y, Kaufman-Francis K, Studdert JB, Steiner KA, Power MD, Loebel DA, et al. The transcrip-
tional and functional properties of mouse epiblast stem cells resemble the anterior primitive streak.
Cell Stem Cell. 2014; 14(1):107–20. doi: 10.1016/j.stem.2013.09.014 PMID: 24139757.
9. Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J, et al. The ground state of embryonic
stem cell self-renewal. Nature. 2008; 453(7194):519–23. doi: 10.1038/nature06968 PMID: 18497825.
10. Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW, Smith A. Promotion of reprogramming
to ground state pluripotency by signal inhibition. PLoS Biol. 2008; 6(10):e253. doi: 10.1371/journal.
pbio.0060253 PMID: 18942890; PubMed Central PMCID: PMC2570424.
11. Silva J, Nichols J, Theunissen TW, Guo G, van Oosten AL, Barrandon O, et al. Nanog is the gateway
to the pluripotent ground state. Cell. 2009; 138(4):722–37. doi: 10.1016/j.cell.2009.07.039 PMID:
19703398; PubMed Central PMCID: PMC3437554.
12. Boroviak T, Loos R, Bertone P, Smith A, Nichols J. The ability of inner-cell-mass cells to self-renew as
embryonic stem cells is acquired following epiblast specification. Nat Cell Biol. 2014; 16(6):516–28.
doi: 10.1038/ncb2965 PMID: 24859004.
13. Rathjen J, Lake JA, Bettess MD, Washington JM, Chapman G, Rathjen PD. Formation of a primitive
ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors. J Cell
Sci. 1999; 112 (Pt 5):601–12. PMID: 9973595.
14. Pelton TA, Sharma S, Schulz TC, Rathjen J, Rathjen PD. Transient pluripotent cell populations during
primitive ectoderm formation: correlation of in vivo and in vitro pluripotent cell development. J Cell Sci.
2002; 115(Pt 2):329–39. PMID: 11839785.
15. Harvey NT, Hughes JN, Lonic A, Yap C, Long C, Rathjen PD, et al. Response to BMP4 signalling dur-
ing ES cell differentiation defines intermediates of the ectoderm lineage. J Cell Sci. 2010; 123(Pt
10):1796–804. doi: 10.1242/jcs.047530 PMID: 20427322.
Regulation of Pluripotent Lineage Progression
PLOS ONE | DOI:10.1371/journal.pone.0163244 October 10, 2016 17 / 21
16. Zhang Y, Li TS, Lee ST, Wawrowsky KA, Cheng K, Galang G, et al. Dedifferentiation and proliferation
of mammalian cardiomyocytes. PloS one. 2010; 5(9):e12559. doi: 10.1371/journal.pone.0012559
PMID: 20838637; PubMed Central PMCID: PMC2933247.
17. Guo G, Yang J, Nichols J, Hall JS, Eyres I, Mansfield W, et al. Klf4 reverts developmentally pro-
grammed restriction of ground state pluripotency. Development. 2009; 136(7):1063–9. doi: 10.1242/
dev.030957 PMID: 19224983; PubMed Central PMCID: PMC2685927.
18. Hanna J, Markoulaki S, Mitalipova M, Cheng AW, Cassady JP, Staerk J, et al. Metastable pluripotent
states in NOD-mouse-derived ESCs. Cell Stem Cell. 2009; 4(6):513–24. doi: 10.1016/j.stem.2009.04.
015 PMID: 19427283; PubMed Central PMCID: PMC2714944.
19. Tan BS, Lonic A, Morris MB, Rathjen PD, Rathjen J. The amino acid transporter SNAT2 mediates L-
proline-induced differentiation of ES cells. Am J Physiol Cell Physiol. 2011; 300(6):C1270–9. doi: 10.
1152/ajpcell.00235.2010 PMID: 21346154.
20. Washington JM, Rathjen J, Felquer F, Lonic A, Bettess MD, Hamra N, et al. L-Proline induces differen-
tiation of ES cells: a novel role for an amino acid in the regulation of pluripotent cells in culture. Am J
Physiol Cell Physiol. 2010; 298(5):C982–92. doi: 10.1152/ajpcell.00498.2009 PMID: 20164384.
21. Casalino L, Comes S, Lambazzi G, De Stefano B, Filosa S, De Falco S, et al. Control of embryonic
stem cell metastability by L-proline catabolism. J Mol Cell Biol. 2011; 3(2):108–22. doi: 10.1093/jmcb/
mjr001 PMID: 21307025.
22. Comes S, Gagliardi M, Laprano N, Fico A, Cimmino A, Palamidessi A, et al. L-Proline Induces a Mes-
enchymal-like Invasive Program in Embryonic Stem Cells by Remodeling H3K9 and H3K36 Methyla-
tion. Stem Cell Reports. 2013; 1(4):307–21. doi: 10.1016/j.stemcr.2013.09.001 PMID: 24319666;
PubMed Central PMCID: PMC3849245.
23. Rathjen J, Rathjen PD. Formation of neural precursor cell populations by differentiation of embryonic
stem cells in vitro. ScientificWorldJournal. 2002; 2:690–700. doi: 10.1100/tsw.2002.134 PMID:
12805994.
24. Lake J, Rathjen J, Remiszewski J, Rathjen PD. Reversible programming of pluripotent cell differentia-
tion. J Cell Sci. 2000; 113 (Pt 3):555–66. PMID: 10639341.
25. Vassilieva S, Goh HN, Lau KX, Hughes JN, Familari M, Rathjen PD, et al. A system to enrich for primi-
tive streak-derivatives, definitive endoderm and mesoderm, from pluripotent cells in culture. PloS one.
2012; 7(6):e38645. doi: 10.1371/journal.pone.0038645 PMID: 22701686; PubMed Central PMCID:
PMC3372479.
26. Hughes JN, Dodge N, Rathjen PD, Rathjen J. A novel role for gamma-secretase in the formation of
primitive streak-like intermediates from ES cells in culture. Stem Cells. 2009; 27(12):2941–51. doi: 10.
1002/stem.218 PMID: 19750540.
27. Rodda SJ, Kavanagh SJ, Rathjen J, Rathjen PD. Embryonic stem cell differentiation and the analysis
of mammalian development. Int J Dev Biol. 2002; 46(4):449–58. PMID: 12141431.
28. Yap C, Goh HN, Familari M, Rathjen PD, Rathjen J. The formation of proximal and distal definitive
endoderm populations in culture requires p38 MAPK activity. J Cell Sci. 2014. doi: 10.1242/jcs.134502
PMID: 24481813.
29. Hughes JN, Washington JM, Zheng Z, Lau XK, Yap C, Rathjen PD, et al. Manipulation of cell:cell con-
tacts and mesoderm suppressing activity direct lineage choice from pluripotent primitive ectoderm-like
cells in culture. PloS one. 2009; 4(5):e5579. doi: 10.1371/journal.pone.0005579 PMID: 19440553;
PubMed Central PMCID: PMC2679147.
30. Ernst M, Gearing DP, Dunn AR. Functional and biochemical association of Hck with the LIF/IL-6 recep-
tor signal transducing subunit gp130 in embryonic stem cells. EMBO J. 1994; 13(7):1574–84. PMID:
8156996; PubMed Central PMCID: PMC394987.
31. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, Smith A. FGF stimulation of the
Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to
lineage commitment. Development. 2007; 134(16):2895–902. doi: 10.1242/dev.02880 PMID:
17660198.
32. Stavridis MP, Lunn JS, Collins BJ, Storey KG. A discrete period of FGF-induced Erk1/2 signalling is
required for vertebrate neural specification. Development. 2007; 134(16):2889–94. doi: 10.1242/dev.
02858 PMID: 17660197.
33. Burdon T, Stracey C, Chambers I, Nichols J, Smith A. Suppression of SHP-2 and ERK signalling pro-
motes self-renewal of mouse embryonic stem cells. Dev Biol. 1999; 210(1):30–43. doi: 10.1006/dbio.
1999.9265 PMID: 10364425.
34. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, et al. The selectivity of protein kinase
inhibitors: a further update. Biochem J. 2007; 408(3):297–315. doi: 10.1042/BJ20070797 PMID:
17850214; PubMed Central PMCID: PMC2267365.
Regulation of Pluripotent Lineage Progression
PLOS ONE | DOI:10.1371/journal.pone.0163244 October 10, 2016 18 / 21
35. Kong L, Deng Z, Shen H, Zhang Y. Src family kinase inhibitor PP2 efficiently inhibits cervical cancer
cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173. Mol Cell
Biochem. 2011; 348(1–2):11–9. doi: 10.1007/s11010-010-0632-1 PMID: 21052789.
36. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, et al. Discovery of a
novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T
cell activation. J Biol Chem. 1996; 271(2):695–701. doi: 10.1074/jbc.271.2.695 PMID: 8557675.
37. Wu JX, Adamson ED. Kinase-negative mutant epidermal growth factor receptor (EGFR) expression
during embryonal stem cell differentiation favours EGFR-independent lineages. Development. 1996;
122(10):3331–42. PMID: 8898244.
38. Meyn MA 3rd, Schreiner SJ, Dumitrescu TP, Nau GJ, Smithgall TE. SRC family kinase activity is
required for murine embryonic stem cell growth and differentiation. Mol Pharmacol. 2005; 68(5):1320–
30. doi: 10.1124/mol.104.010231 PMID: 15985613.
39. Meyn MA 3rd, Smithgall TE. Chemical genetics identifies c-Src as an activator of primitive ectoderm
formation in murine embryonic stem cells. Sci Signal. 2009; 2(92):ra64. doi: 10.1126/scisignal.
2000311 PMID: 19825829; PubMed Central PMCID: PMC2775445.
40. Aouadi M, Bost F, Caron L, Laurent K, Le Marchand Brustel Y, Binetruy B. p38 mitogen-activated pro-
tein kinase activity commits embryonic stem cells to either neurogenesis or cardiomyogenesis. Stem
Cells. 2006; 24(5):1399–406. doi: 10.1634/stemcells.2005-0398 PMID: 16424397.
41. Chen S, Do JT, Zhang Q, Yao S, Yan F, Peters EC, et al. Self-renewal of embryonic stem cells by a
small molecule. Proc Natl Acad Sci U S A. 2006; 103(46):17266–71. doi: 10.1073/pnas.0608156103
PMID: 17088537; PubMed Central PMCID: PMC1859921.
42. Wu J, Kubota J, Hirayama J, Nagai Y, Nishina S, Yokoi T, et al. p38 Mitogen-activated protein kinase
controls a switch between cardiomyocyte and neuronal commitment of murine embryonic stem cells
by activating myocyte enhancer factor 2C-dependent bone morphogenetic protein 2 transcription.
Stem Cells Dev. 2010; 19(11):1723–34. doi: 10.1089/scd.2010.0066 PMID: 20412016.
43. Barruet E, Hadadeh O, Peiretti F, Renault VM, Hadjal Y, Bernot D, et al. p38 mitogen activated protein
kinase controls two successive-steps during the early mesodermal commitment of embryonic stem
cells. Stem Cells Dev. 2011; 20(7):1233–46. doi: 10.1089/scd.2010.0213 PMID: 20954847.
44. Ying QL, Stavridis M, Griffiths D, Li M, Smith A. Conversion of embryonic stem cells into neuroectoder-
mal precursors in adherent monoculture. Nat Biotechnol. 2003; 21(2):183–6. doi: 10.1038/nbt780
PMID: 12524553.
45. Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L, et al. SU6656, a selective src family kinase
inhibitor, used to probe growth factor signaling. Mol Cell Biol. 2000; 20(23):9018–27. doi: 10.1128/
mcb.20.23.9018-9027.2000 PMID: 11074000; PubMed Central PMCID: PMCPMC86555.
46. Williams MR, Arthur JS, Balendran A, van der Kaay J, Poli V, Cohen P, et al. The role of 3-phosphoino-
sitide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol.
2000; 10(8):439–48. doi: 10.1016/s0960-9822(00)00441-3 PMID: 10801415.
47. Anneren C, Cowan CA, Melton DA. The Src family of tyrosine kinases is important for embryonic stem
cell self-renewal. J Biol Chem. 2004; 279(30):31590–8. doi: 10.1074/jbc.M403547200 PMID:
15148312.
48. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, et al. A novel kinase cas-
cade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the
small heat shock proteins. Cell. 1994; 78(6):1027–37. doi: 10.1016/0092-8674(94)90277-1 PMID:
7923353.
49. Darragh J, Soloaga A, Beardmore VA, Wingate AD, Wiggin GR, Peggie M, et al. MSKs are required for
the transcription of the nuclear orphan receptors Nur77, Nurr1 and Nor1 downstream of MAPK signal-
ling. Biochem J. 2005; 390(Pt 3):749–59. doi: 10.1042/BJ20050196 PMID: 15910281; PubMed Central
PMCID: PMC1199668.
50. Allen M, Svensson L, Roach M, Hambor J, McNeish J, Gabel CA. Deficiency of the stress kinase
p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses
of enzyme-deficient embryonic stem cells. J Exp Med. 2000; 191(5):859–70. PMID: 10704466;
PubMed Central PMCID: PMC2195860.
51. Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P. Intracellular reactive oxygen species acti-
vate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol.
2005; 25(15):6391–403. doi: 10.1128/MCB.25.15.6391–6403.2005 PMID: 16024778; PubMed Central
PMCID: PMC1190365.
52. Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J. 2010; 429
(3):403–17. doi: 10.1042/BJ20100323 PMID: 20626350.
Regulation of Pluripotent Lineage Progression
PLOS ONE | DOI:10.1371/journal.pone.0163244 October 10, 2016 19 / 21
53. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cel-
lular signaling. Cell Signal. 2012; 24(5):981–90. doi: 10.1016/j.cellsig.2012.01.008 PMID: 22286106;
PubMed Central PMCID: PMC3454471.
54. Choi TG, Lee J, Ha J, Kim SS. Apoptosis signal-regulating kinase 1 is an intracellular inducer of p38
MAPK-mediated myogenic signalling in cardiac myoblasts. Biochim Biophys Acta. 2011; 1813
(8):1412–21. doi: 10.1016/j.bbamcr.2011.04.001 PMID: 21530592.
55. Liu W, Phang JM. Proline dehydrogenase (oxidase) in cancer. Biofactors. 2012; 38(6):398–406. doi:
10.1002/biof.1036 PMID: 22886911.
56. Hamilton WB, Kaji K, Kunath T. ERK2 suppresses self-renewal capacity of embryonic stem cells, but
is not required for multi-lineage commitment. PloS one. 2013; 8(4):e60907. doi: 10.1371/journal.pone.
0060907 PMID: 23613754; PubMed Central PMCID: PMC3628700.
57. Shimizu T, Ueda J, Ho JC, Iwasaki K, Poellinger L, Harada I, et al. Dual inhibition of Src and GSK3
maintains mouse embryonic stem cells, whose differentiation is mechanically regulated by Src signal-
ing. Stem Cells. 2012; 30(7):1394–404. doi: 10.1002/stem.1119 PMID: 22553165.
58. Li X, Zhu L, Yang A, Lin J, Tang F, Jin S, et al. Calcineurin-NFAT signaling critically regulates early line-
age specification in mouse embryonic stem cells and embryos. Cell Stem Cell. 2011; 8(1):46–58. doi:
10.1016/j.stem.2010.11.027 PMID: 21211781.
59. Theunissen TW, Powell BE, Wang H, Mitalipova M, Faddah DA, Reddy J, et al. Systematic Identifica-
tion of Culture Conditions for Induction and Maintenance of Naive Human Pluripotency. Cell Stem Cell.
2014. doi: 10.1016/j.stem.2014.07.002 PMID: 25090446.
60. Vallier L, Mendjan S, Brown S, Chng Z, Teo A, Smithers LE, et al. Activin/Nodal signalling maintains
pluripotency by controlling Nanog expression. Development. 2009; 136(8):1339–49. doi: 10.1242/dev.
033951 PMID: 19279133; PubMed Central PMCID: PMC2687465.
61. Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M, et al. Histone deacetylase inhibition elicits
an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell. 2009; 4
(4):359–69. doi: 10.1016/j.stem.2009.03.001 PMID: 19341625; PubMed Central PMCID:
PMC2719860.
62. Ding VM, Boersema PJ, Foong LY, Preisinger C, Koh G, Natarajan S, et al. Tyrosine phosphorylation
profiling in FGF-2 stimulated human embryonic stem cells. PloS one. 2011; 6(3):e17538. doi: 10.1371/
journal.pone.0017538 PMID: 21437283; PubMed Central PMCID: PMC3060089.
63. Tamm C, Galito SP, Anneren C. Differential effects on cell motility, embryonic stem cell self-renewal
and senescence by diverse Src kinase family inhibitors. Exp Cell Res. 2012; 318(4):336–49. doi: 10.
1016/j.yexcr.2011.12.008 PMID: 22197704.
64. Chakraborty S, Kang B, Huang F, Guo YL. Mouse embryonic stem cells lacking p38alpha and
p38delta can differentiate to endothelial cells, smooth muscle cells, and epithelial cells. Differentiation.
2009; 78(2–3):143–50. doi: 10.1016/j.diff.2009.05.006 PMID: 19539422; PubMed Central PMCID:
PMCPMC2761660.
65. Toyooka Y, Shimosato D, Murakami K, Takahashi K, Niwa H. Identification and characterization of
subpopulations in undifferentiated ES cell culture. Development. 2008; 135(5):909–18. doi: 10.1242/
dev.017400 PMID: 18263842.
66. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, et al. The homeoprotein Nanog is
required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 2003; 113(5):631–42.
doi: 10.1016/s0092-8674(03)00393-3 PMID: 12787504.
67. Hayashi K, Lopes SM, Tang F, Surani MA. Dynamic equilibrium and heterogeneity of mouse pluripo-
tent stem cells with distinct functional and epigenetic states. Cell Stem Cell. 2008; 3(4):391–401. doi:
10.1016/j.stem.2008.07.027 PMID: 18940731; PubMed Central PMCID: PMC3847852.
68. Chambers I, Silva J, Colby D, Nichols J, Nijmeijer B, Robertson M, et al. Nanog safeguards pluripo-
tency and mediates germline development. Nature. 2007; 450(7173):1230–4. doi: 10.1038/
nature06403 PMID: 18097409.
69. Acampora D, Di Giovannantonio LG, Simeone A. Otx2 is an intrinsic determinant of the embryonic
stem cell state and is required for transition to a stable epiblast stem cell condition. Development.
2013; 140(1):43–55. doi: 10.1242/dev.085290 PMID: 23154415.
70. Furusawa T, Ohkoshi K, Honda C, Takahashi S, Tokunaga T. Embryonic stem cells expressing both
platelet endothelial cell adhesion molecule-1 and stage-specific embryonic antigen-1 differentiate pre-
dominantly into epiblast cells in a chimeric embryo. Biol Reprod. 2004; 70(5):1452–7. doi: 10.1095/
biolreprod.103.024190 PMID: 14736812.
71. Yang SH, Kalkan T, Morissroe C, Marks H, Stunnenberg H, Smith A, et al. Otx2 and Oct4 Drive Early
Enhancer Activation during Embryonic Stem Cell Transition from Naive Pluripotency. Cell Rep. 2014;
7(6):1968–81. doi: 10.1016/j.celrep.2014.05.037 PMID: 24931607; PubMed Central PMCID:
PMC4074343.
Regulation of Pluripotent Lineage Progression
PLOS ONE | DOI:10.1371/journal.pone.0163244 October 10, 2016 20 / 21
72. Hu G, Kim J, Xu Q, Leng Y, Orkin SH, Elledge SJ. A genome-wide RNAi screen identifies a new tran-
scriptional module required for self-renewal. Genes Dev. 2009; 23(7):837–48. doi: 10.1101/gad.
1769609 PMID: 19339689; PubMed Central PMCID: PMC2666338.
73. Westerman BA, Braat AK, Taub N, Potman M, Vissers JH, Blom M, et al. A genome-wide RNAi screen
in mouse embryonic stem cells identifies Mp1 as a key mediator of differentiation. J Exp Med. 2011;
208(13):2675–89. doi: 10.1084/jem.20102037 PMID: 22143885; PubMed Central PMCID:
PMC3244037.
74. Wong DJ, Liu H, Ridky TW, Cassarino D, Segal E, Chang HY. Module map of stem cell genes guides
creation of epithelial cancer stem cells. Cell Stem Cell. 2008; 2(4):333–44. doi: 10.1016/j.stem.2008.
02.009 PMID: 18397753; PubMed Central PMCID: PMC2628721.
75. Kim J, Chu J, Shen X, Wang J, Orkin SH. An extended transcriptional network for pluripotency of
embryonic stem cells. Cell. 2008; 132(6):1049–61. doi: 10.1016/j.cell.2008.02.039 PMID: 18358816;
PubMed Central PMCID: PMC3837340.
76. Kim J, Woo AJ, Chu J, Snow JW, Fujiwara Y, Kim CG, et al. A Myc network accounts for similarities
between embryonic stem and cancer cell transcription programs. Cell. 2010; 143(2):313–24. doi: 10.
1016/j.cell.2010.09.010 PMID: 20946988; PubMed Central PMCID: PMC3018841.
77. Nichols J, Silva J, Roode M, Smith A. Suppression of Erk signalling promotes ground state pluripo-
tency in the mouse embryo. Development. 2009; 136(19):3215–22. doi: 10.1242/dev.038893 PMID:
19710168; PubMed Central PMCID: PMC2739140.
78. Donald SP, Sun XY, Hu CA, Yu J, Mei JM, Valle D, et al. Proline oxidase, encoded by p53-induced
gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res. 2001; 61
(5):1810–5. PMID: 11280728.
79. Liu Y, Borchert GL, Surazynski A, Hu CA, Phang JM. Proline oxidase activates both intrinsic and
extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Onco-
gene. 2006; 25(41):5640–7. doi: 10.1038/sj.onc.1209564 PMID: 16619034.
80. Lee SH, Lee YJ, Park SW, Kim HS, Han HJ. Caveolin-1 and integrin beta1 regulate embryonic stem
cell proliferation via p38 MAPK and FAK in high glucose. J Cell Physiol. 2011; 226(7):1850–9. doi: 10.
1002/jcp.22510 PMID: 21506116.
81. Rathjen J, Haines BP, Hudson KM, Nesci A, Dunn S, Rathjen PD. Directed differentiation of pluripotent
cells to neural lineages: homogeneous formation and differentiation of a neurectoderm population.
Development. 2002; 129(11):2649–61. PMID: 12015293.
82. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R. The in vitro development of blastocyst-
derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J
Embryol Exp Morphol. 1985; 87:27–45. PMID: 3897439.
83. Rathjen J, Rathjen PD. Lineage specific differentiation of mouse ES cells: formation and differentiation
of early primitive ectoderm-like (EPL) cells. Methods Enzymol. 2003; 365:3–25. doi: 10.1016/S0076-
6879(03)65001-9 PMID: 14696334.
84. Simon P. Q-Gene: processing quantitative real-time RT-PCR data. Bioinformatics. 2003; 19
(11):1439–40. doi: 10.1093/bioinformatics/btg157 PMID: 12874059.
Regulation of Pluripotent Lineage Progression
PLOS ONE | DOI:10.1371/journal.pone.0163244 October 10, 2016 21 / 21
